HEADER IMMUNE SYSTEM 09-JAN-14 4OD1 TITLE CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.03, A POTENT V1V2-DIRECTED TITLE 2 HIV-1 NEUTRALIZING ANTIBODY COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAP256-VRC26.03 HEAVY CHAIN; COMPND 3 CHAIN: H; COMPND 4 FRAGMENT: FAB; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: CAP256-VRC26.03 LIGHT CHAIN; COMPND 8 CHAIN: L; COMPND 9 FRAGMENT: FAB; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 16 EXPRESSION_SYSTEM_CELL_LINE: HEK293 KEYWDS FAB, HIV-1, V1V2, CAP256, VRC26, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.GORMAN,N.A.DORIA-ROSE,C.A.SCHRAMM,P.L.MOORE,J.R.MASCOLA,L.SHAPIRO, AUTHOR 2 L.MORRIS,P.D.KWONG REVDAT 6 06-NOV-24 4OD1 1 REMARK REVDAT 5 06-DEC-23 4OD1 1 REMARK REVDAT 4 20-SEP-23 4OD1 1 LINK REVDAT 3 14-MAY-14 4OD1 1 JRNL REVDAT 2 02-APR-14 4OD1 1 JRNL REVDAT 1 26-FEB-14 4OD1 0 JRNL AUTH N.A.DORIA-ROSE,C.A.SCHRAMM,J.GORMAN,P.L.MOORE,J.N.BHIMAN, JRNL AUTH 2 B.J.DEKOSKY,M.J.ERNANDES,I.S.GEORGIEV,H.J.KIM,M.PANCERA, JRNL AUTH 3 R.P.STAUPE,H.R.ALTAE-TRAN,R.T.BAILER,E.T.CROOKS,A.CUPO, JRNL AUTH 4 A.DRUZ,N.J.GARRETT,K.H.HOI,R.KONG,M.K.LOUDER,N.S.LONGO, JRNL AUTH 5 K.MCKEE,M.NONYANE,S.O'DELL,R.S.ROARK,R.S.RUDICELL, JRNL AUTH 6 S.D.SCHMIDT,D.J.SHEWARD,C.SOTO,C.K.WIBMER,Y.YANG,Z.ZHANG, JRNL AUTH 7 NISC COMPARATIVE SEQUENCING,J.C.MULLIKIN,J.M.BINLEY, JRNL AUTH 8 R.W.SANDERS,I.A.WILSON,J.P.MOORE,A.B.WARD,G.GEORGIOU, JRNL AUTH 9 C.WILLIAMSON,S.S.ABDOOL KARIM,L.MORRIS,P.D.KWONG,L.SHAPIRO, JRNL AUTH10 J.R.MASCOLA JRNL TITL DEVELOPMENTAL PATHWAY FOR POTENT V1V2-DIRECTED JRNL TITL 2 HIV-NEUTRALIZING ANTIBODIES. JRNL REF NATURE V. 509 55 2014 JRNL REFN ISSN 0028-0836 JRNL PMID 24590074 JRNL DOI 10.1038/NATURE13036 REMARK 2 REMARK 2 RESOLUTION. 2.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.2_1309) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.14 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 86.2 REMARK 3 NUMBER OF REFLECTIONS : 13071 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 654 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.1441 - 4.5972 0.99 2908 153 0.1790 0.2283 REMARK 3 2 4.5972 - 3.6497 0.99 2861 151 0.1817 0.2045 REMARK 3 3 3.6497 - 3.1886 0.95 2734 144 0.2158 0.2624 REMARK 3 4 3.1886 - 2.8971 0.83 2354 124 0.2603 0.2920 REMARK 3 5 2.8971 - 2.6895 0.54 1560 82 0.2962 0.3524 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.630 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 3538 REMARK 3 ANGLE : 0.805 4817 REMARK 3 CHIRALITY : 0.031 537 REMARK 3 PLANARITY : 0.004 616 REMARK 3 DIHEDRAL : 12.069 1260 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4OD1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-JAN-14. REMARK 100 THE DEPOSITION ID IS D_1000084338. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-FEB-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13074 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.690 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.4 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.15000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.69 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 50.1 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : 0.44000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3U4E REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 22% PEG8000, 5% MPD, 0.1 M IMIDAZOLE, REMARK 280 CRYOPROTECTANT: 20% XYLITOL, PH 6.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 49.51150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.38650 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 49.51150 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.38650 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3300 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH H 308 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS H 214 REMARK 465 SER H 215 REMARK 465 CYS H 216 REMARK 465 ASP H 217 REMARK 465 LYS H 218 REMARK 465 GLY H 219 REMARK 465 LEU H 220 REMARK 465 GLU H 221 REMARK 465 VAL H 222 REMARK 465 LEU H 223 REMARK 465 PHE H 224 REMARK 465 GLN H 225 REMARK 465 GLN L 1 REMARK 465 SER L 2 REMARK 465 THR L 209 REMARK 465 GLU L 210 REMARK 465 CYS L 211 REMARK 465 SER L 212 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER H 28 89.04 -66.20 REMARK 500 VAL H 48 -62.53 -102.90 REMARK 500 ARG H 66 -43.55 -136.89 REMARK 500 ASP H 100J 56.90 -165.40 REMARK 500 ASP H 101A -72.61 -71.91 REMARK 500 SER H 113 40.31 -90.91 REMARK 500 ASP H 144 76.16 53.60 REMARK 500 PRO H 147 -134.86 -86.05 REMARK 500 CYS L 23 87.92 -150.50 REMARK 500 SER L 26 -168.92 -107.85 REMARK 500 ASN L 30 74.08 -152.68 REMARK 500 ASN L 31 -162.52 -171.06 REMARK 500 ASN L 51 -58.47 67.69 REMARK 500 ASN L 52 47.92 -150.55 REMARK 500 ALA L 84 -176.55 -172.18 REMARK 500 TRP L 91 73.05 -111.20 REMARK 500 LEU L 95 -71.97 -114.51 REMARK 500 ARG L 96 76.88 53.29 REMARK 500 ALA L 143 117.75 -167.59 REMARK 500 ASP L 151 -105.61 45.98 REMARK 500 HIS L 197 115.47 -160.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4OCR RELATED DB: PDB REMARK 900 ANTIBODY FROM THE SAME LINEAGE REMARK 900 RELATED ID: 4OCS RELATED DB: PDB REMARK 900 ANTIBODY FROM THE SAME LINEAGE REMARK 900 RELATED ID: 4OCW RELATED DB: PDB REMARK 900 ANTIBODY FROM THE SAME LINEAGE REMARK 900 RELATED ID: 4OD3 RELATED DB: PDB REMARK 900 ANTIBODY FROM THE SAME LINEAGE REMARK 900 RELATED ID: 4ODH RELATED DB: PDB REMARK 900 ANTIBODY FROM THE SAME LINEAGE REMARK 900 RELATED ID: 4ORG RELATED DB: PDB REMARK 900 ANTIBODY FROM THE SAME LINEAGE DBREF 4OD1 H 2 225 PDB 4OD1 4OD1 2 225 DBREF 4OD1 L 1 212 PDB 4OD1 4OD1 1 212 SEQRES 1 H 255 VAL GLN LEU VAL GLU SER GLY GLY GLY VAL VAL GLN PRO SEQRES 2 H 255 GLY LYS SER LEU ARG LEU SER CYS ALA ALA SER ARG PHE SEQRES 3 H 255 SER PHE ASN ARG TYR GLY MET HIS TRP VAL ARG GLN ALA SEQRES 4 H 255 PRO GLY LYS GLY LEU GLU TRP VAL ALA ALA ILE SER TYR SEQRES 5 H 255 ASP GLY THR ASP LYS TYR HIS ALA ASP LYS VAL TRP GLY SEQRES 6 H 255 ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR LEU SEQRES 7 H 255 TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR ALA SEQRES 8 H 255 LEU TYR TYR CYS ALA LYS ASP LEU ARG GLU ASP GLU CYS SEQRES 9 H 255 GLU GLU TRP TRP SER ASP TYS TYS ASP PHE GLY LYS GLN SEQRES 10 H 255 LEU PRO CYS ARG LYS SER ARG GLY VAL ALA GLY ILE PHE SEQRES 11 H 255 ASP GLY TRP GLY GLN GLY THR MET VAL THR VAL SER SER SEQRES 12 H 255 ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SEQRES 13 H 255 SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU GLY SEQRES 14 H 255 CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SEQRES 15 H 255 SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS THR SEQRES 16 H 255 PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER LEU SEQRES 17 H 255 SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY THR SEQRES 18 H 255 GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER ASN SEQRES 19 H 255 THR LYS VAL ASP LYS ARG VAL GLU PRO LYS SER CYS ASP SEQRES 20 H 255 LYS GLY LEU GLU VAL LEU PHE GLN SEQRES 1 L 217 GLN SER VAL LEU THR GLN PRO PRO SER VAL SER ALA ALA SEQRES 2 L 217 PRO GLY GLN LYS VAL THR ILE SER CYS SER GLY SER SER SEQRES 3 L 217 SER ASN ILE GLY ASN ASN PHE VAL SER TRP TYR GLN GLN SEQRES 4 L 217 ARG PRO GLY THR ALA PRO LYS ILE LEU ILE TYR GLU ASN SEQRES 5 L 217 ASN LYS ARG PRO SER GLU THR PRO ASP ARG PHE SER GLY SEQRES 6 L 217 SER LYS SER GLY THR SER ALA THR LEU ALA ILE THR GLY SEQRES 7 L 217 LEU GLN THR ALA ASP GLU ALA GLU TYR TYR CYS ALA THR SEQRES 8 L 217 TRP SER ALA SER LEU SER SER ALA ARG VAL PHE GLY THR SEQRES 9 L 217 GLY THR ARG ILE THR VAL LEU GLY GLN PRO LYS ALA ASN SEQRES 10 L 217 PRO THR VAL THR LEU PHE PRO PRO SER SER GLU GLU LEU SEQRES 11 L 217 GLN ALA ASN LYS ALA THR LEU VAL CYS LEU ILE SER ASP SEQRES 12 L 217 PHE TYR PRO GLY ALA VAL THR VAL ALA TRP LYS ALA ASP SEQRES 13 L 217 SER SER PRO VAL LYS ALA GLY VAL GLU THR THR THR PRO SEQRES 14 L 217 SER LYS GLN SER ASN ASN LYS TYR ALA ALA SER SER TYR SEQRES 15 L 217 LEU SER LEU THR PRO GLU GLN TRP LYS SER HIS ARG SER SEQRES 16 L 217 TYR SER CYS GLN VAL THR HIS GLU GLY SER THR VAL GLU SEQRES 17 L 217 LYS THR VAL ALA PRO THR GLU CYS SER MODRES 4OD1 TYS H 100H TYR O-SULFO-L-TYROSINE MODRES 4OD1 TYS H 100I TYR O-SULFO-L-TYROSINE HET TYS H 100H 25 HET TYS H 100I 24 HETNAM TYS O-SULFO-L-TYROSINE FORMUL 1 TYS 2(C9 H11 N O6 S) FORMUL 3 HOH *43(H2 O) HELIX 1 1 SER H 28 ASN H 30 5 3 HELIX 2 2 ARG H 83 THR H 87 5 5 HELIX 3 3 SER H 127 LYS H 129 5 3 HELIX 4 4 SER H 156 ALA H 158 5 3 HELIX 5 5 LYS H 201 ASN H 204 5 4 HELIX 6 6 GLN L 79 GLU L 83 5 5 HELIX 7 7 SER L 121 GLN L 126 1 6 HELIX 8 8 THR L 181 HIS L 188 1 8 SHEET 1 A 4 GLN H 3 SER H 7 0 SHEET 2 A 4 LEU H 18 SER H 25 -1 O SER H 21 N SER H 7 SHEET 3 A 4 THR H 77 MET H 82 -1 O MET H 82 N LEU H 18 SHEET 4 A 4 PHE H 67 ASP H 72 -1 N ASP H 72 O THR H 77 SHEET 1 B 6 VAL H 11 VAL H 12 0 SHEET 2 B 6 THR H 107 VAL H 111 1 O THR H 110 N VAL H 12 SHEET 3 B 6 ALA H 88 GLU H 98 -1 N TYR H 90 O THR H 107 SHEET 4 B 6 TYR H 32 GLN H 39 -1 N VAL H 37 O TYR H 91 SHEET 5 B 6 LEU H 45 ILE H 51 -1 O GLU H 46 N ARG H 38 SHEET 6 B 6 LYS H 57 HIS H 59 -1 O TYR H 58 N ALA H 50 SHEET 1 C 4 VAL H 11 VAL H 12 0 SHEET 2 C 4 THR H 107 VAL H 111 1 O THR H 110 N VAL H 12 SHEET 3 C 4 ALA H 88 GLU H 98 -1 N TYR H 90 O THR H 107 SHEET 4 C 4 PHE H 101 TRP H 103 -1 O GLY H 102 N LYS H 94 SHEET 1 D 2 CYS H 100A TRP H 100D 0 SHEET 2 D 2 CYS H 100Q SER H 100T-1 O ARG H 100R N GLU H 100C SHEET 1 E 4 SER H 120 LEU H 124 0 SHEET 2 E 4 THR H 135 TYR H 145 -1 O GLY H 139 N LEU H 124 SHEET 3 E 4 TYR H 176 PRO H 185 -1 O VAL H 184 N ALA H 136 SHEET 4 E 4 VAL H 163 THR H 165 -1 N HIS H 164 O VAL H 181 SHEET 1 F 4 THR H 131 SER H 132 0 SHEET 2 F 4 THR H 135 TYR H 145 -1 O THR H 135 N SER H 132 SHEET 3 F 4 TYR H 176 PRO H 185 -1 O VAL H 184 N ALA H 136 SHEET 4 F 4 VAL H 169 LEU H 170 -1 N VAL H 169 O SER H 177 SHEET 1 G 3 THR H 151 TRP H 154 0 SHEET 2 G 3 TYR H 194 HIS H 200 -1 O ASN H 197 N SER H 153 SHEET 3 G 3 THR H 205 VAL H 211 -1 O VAL H 207 N VAL H 198 SHEET 1 H 4 LEU L 4 THR L 5 0 SHEET 2 H 4 VAL L 19 GLY L 25 -1 O SER L 24 N THR L 5 SHEET 3 H 4 SER L 70 ILE L 75 -1 O ILE L 75 N VAL L 19 SHEET 4 H 4 PHE L 62 SER L 67 -1 N SER L 63 O ALA L 74 SHEET 1 I 5 SER L 9 ALA L 13 0 SHEET 2 I 5 THR L 102 VAL L 106 1 O ARG L 103 N VAL L 11 SHEET 3 I 5 GLU L 85 THR L 90 -1 N TYR L 86 O THR L 102 SHEET 4 I 5 SER L 34 GLN L 38 -1 N GLN L 38 O GLU L 85 SHEET 5 I 5 LYS L 45 ILE L 48 -1 O ILE L 48 N TRP L 35 SHEET 1 J 4 SER L 9 ALA L 13 0 SHEET 2 J 4 THR L 102 VAL L 106 1 O ARG L 103 N VAL L 11 SHEET 3 J 4 GLU L 85 THR L 90 -1 N TYR L 86 O THR L 102 SHEET 4 J 4 VAL L 97 PHE L 98 -1 O VAL L 97 N THR L 90 SHEET 1 K 4 THR L 114 PHE L 118 0 SHEET 2 K 4 ALA L 130 PHE L 139 -1 O LEU L 135 N THR L 116 SHEET 3 K 4 TYR L 172 LEU L 180 -1 O ALA L 174 N ILE L 136 SHEET 4 K 4 VAL L 159 THR L 161 -1 N GLU L 160 O TYR L 177 SHEET 1 L 4 THR L 114 PHE L 118 0 SHEET 2 L 4 ALA L 130 PHE L 139 -1 O LEU L 135 N THR L 116 SHEET 3 L 4 TYR L 172 LEU L 180 -1 O ALA L 174 N ILE L 136 SHEET 4 L 4 SER L 165 LYS L 166 -1 N SER L 165 O ALA L 173 SHEET 1 M 4 SER L 153 VAL L 155 0 SHEET 2 M 4 THR L 145 ALA L 150 -1 N ALA L 150 O SER L 153 SHEET 3 M 4 TYR L 191 HIS L 197 -1 O GLN L 194 N ALA L 147 SHEET 4 M 4 SER L 200 VAL L 206 -1 O LYS L 204 N CYS L 193 SSBOND 1 CYS H 22 CYS H 92 1555 1555 2.03 SSBOND 2 CYS H 100A CYS H 100Q 1555 1555 2.03 SSBOND 3 CYS H 140 CYS H 196 1555 1555 2.03 SSBOND 4 CYS L 23 CYS L 88 1555 1555 2.03 SSBOND 5 CYS L 134 CYS L 193 1555 1555 2.03 LINK C ASP H 100G N TYS H 100H 1555 1555 1.33 LINK C TYS H 100H N TYS H 100I 1555 1555 1.34 LINK C TYS H 100I N ASP H 100J 1555 1555 1.34 CISPEP 1 PRO H 41 GLY H 42 0 -0.20 CISPEP 2 TYS H 100I ASP H 100J 0 -15.76 CISPEP 3 ASP H 100J PHE H 100K 0 4.82 CISPEP 4 ALA H 100X GLY H 100Y 0 3.01 CISPEP 5 PHE H 146 PRO H 147 0 -1.34 CISPEP 6 GLU H 148 PRO H 149 0 -5.74 CISPEP 7 SER L 95B ALA L 95C 0 6.91 CISPEP 8 ALA L 95C ARG L 96 0 -6.66 CISPEP 9 THR L 100 GLY L 101 0 -0.74 CISPEP 10 TYR L 140 PRO L 141 0 -0.86 CRYST1 99.023 70.773 87.539 90.00 116.69 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010099 0.000000 0.005077 0.00000 SCALE2 0.000000 0.014130 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012786 0.00000